Stem Cells Market to Reach USD 32.8 Billion by 2032 | CAGR: 9.9% | DataHorizzon Research

Fort Collins, Colorado, Sept. 06, 2023 (GLOBE NEWSWIRE) — DataHorizzon Research Published a report titled, “Stem Cells Market Size, Growth, Share, Statistics Report, By Product Type, By Application Type (Regenerative Medicine, Drug Discovery And Development), By Technology Type, By Therapy Type (Autologous And Allogeneic), By End-user Type, By Region, And Segment Forecasts, 2023-2032.”

According to DataHorizzon Research, The global stem cells market accounted for a high share in 2022 and is projected to reach a market size of USD 32.8 Billion at a CAGR of 9.9% by 2032. The breakthroughs in the research and knowledge industry are projected to impel market growth in the forthcoming years. The ongoing research and development in clinical trials is also anticipated to widen owing to the increased adoption of regenerative medicine and associated studies.

Request Sample Report:

Report Snapshot:

Report Title Stem Cells Market
Market Size in 2022 USD 12.8 Billion
Market Size by 2032 USD 32.8 Billion
CAGR from 2023 to 2032 9.9%
Largest Market North America
Forecast Period 2023 to 2032
Historic Period 2021
Base Year 2022
Report Scope & Coverage Market size, estimations, competitor analysis, trends, and growth factors
By Product Type Adult stem cells, induced pluripotent stem cells, human embryonic stem cells, tiny embryonic-like stem cells
By Application Regenerative medicine, drug discovery, and development
By Technology Cryopreservation, cell production, cell acquisition, wounds & injuries, expansion, and sub-culture
By Therapy Type Autologous and allogeneic
By End-user Hospitals, academic & research institutes, pharmaceutical & biotechnology companies, others
Region North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Countries Covered U.S., Canada, U.K., Germany, France, China, India, Japan, South Korea, Brazil, Mexico, UAE, Saudi Arabia, and South Africa, among others
Major Market Players Thermo Fisher Scientific, Merck KGaA, Stem Cell Technologies Inc., Becton, Dickinson and Company, Novartis AG, Pluristem Therapeutics Inc., Advanced Cell Technology Inc., Osiris Therapeutics, Angel Biotechnology, Celgene Corporation, Brainstorm Cell Therapeutics, Lonza, PromoCell GmbH.

Segmentation Overview:

The stem cells market has been segmented into product, application, technology, therapy, end-user, and region. Based on the product, adult cells represented a large share and continue to dominate the market. Based on application, regenerative medicine accounted for a significant portion of the market. Cell acquisition accounted for a prominent position in the global market based on technology.

Geographically, North America is a dominant stem cell market due to the robust infrastructure and high spending on research trials. Followed by significant investments in the healthcare industry, possibilities of advanced treatment have emerged that can decode the market challenges. The presence of regulatory bodies such as the FDA and Health Canada have enforced stringent safety and efficacy standards.

Key Developments in the Industry:

  • Stem cells offer a lot of potential for regenerative medicine and are vital to developmental biology. In June 2023, Cambridge scientists created a stem-cell model of the human embryo by reprogramming human stem cells, according to a paper published in the Nature’s Journal. The purpose of the stem-cell model is to facilitate the researchers with knowledge about embryo systems and specialized cells such as eggs and sperm and to understand the factors related to loss during early pregnancy stages.
  • In a recent study published on aging hair follicle stem cells by Northwestern University, Illinois. The study describes how scientists have discovered that hair follicles can be softened to enable hair growth. The study also highlights that stem cells can be softened by expediting the production of RNA cells miR-205 in the hair. The research was conducted on mice, and scientists observed that the genetic manipulations to the stem cells produced more miR-205, which was responsible for hair growth in young and old mice.

Buy This Research Report:

Stem Cells Market Report Highlights:

  • The stem cells market is projected to attain a CAGR of 9.9% by 2032.
  • Adult stem cells registered positive growth in the past and remained dominant in the following years. Availability of cryopreservation and stem cell banking are some of the prominent factors for segment growth.
  • Regenerative medicine accounts for a significant position in the application segment owing to the rise in approvals for stem cell therapies.
  • Allogenic therapy is a dominating segment for stem cell therapy owing to its popularity in transplant procedures.
  • North America is a dominant market for stem cell therapies due to the presence of robust infrastructure, and high spending capacity on cell research and development. Besides, the rise in cancer cases is a significant factor for market development in North America.
  • The prominent players in the stem cell market are Thermo Fisher Scientific, Merck KGaA, Stem Cell Technologies Inc., Becton, Dickinson, and Company, Novartis AG, Pluristem Therapeutics Inc., Advanced Cell Technology Inc., Osiris Therapeutics, Angel Biotechnology, Celgene Corporation, Brainstorm Cell Therapeutics, Lonza, and PromoCell GmbH

Looking Exclusively For Region/Country Specific Report?


Ask For Discount

Stem Cells Market Report Segmentation:

Stem Cells Market, By Product Type (2023-2032)

  • Adult Stem Cells
  • Induced Pluripotent 
  • Human Embryonic
  • Very Small Embryonic 

Stem Cells Market, By Application Type (2023-2032)

  • Regenerative Medicine
  • Drug Discovery and Development

Stem Cells Market, By Technology Type (2023-2032)

  • Cryopreservation
  • Cell Production
  • Cell Acquisition
  • Wounds & injuries
  • Expansion and Sub-culture

Stem Cells Market, By Therapy Type (2023-2032)

  • Autologous
  • Allogeneic

Stem Cells Market, By End-user Type (2023-2032)

  • Hospitals
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

Stem Cells Market, By Region (2023-2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa

About DataHorizzon Research:

DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.



Ph: +1-970-672-0390


Follow Us:  LinkedIn

Recent Publications:

Coronary Stent Market 2023 to 2032
Digital Health Market 2023 to 2032
Digital Genome Market 2023 to 2032
Cancer Immunotherapy Market 2023 to 2032
Contact Lenses Market 2023 to 2032



CONTACT: Mail: Ph: +1-970-672-0390 Website: 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More